A Rapid Molecular Detection Tool for Toxigenic M1UK Streptococcus pyogenes
- PMID: 39206960
- PMCID: PMC11841628
- DOI: 10.1093/infdis/jiae437
A Rapid Molecular Detection Tool for Toxigenic M1UK Streptococcus pyogenes
Abstract
Background: The gradual replacement of the Streptococcus pyogenes M1global genotype by a newly emergent M1UK variant is a global public health threat warranting increased surveillance. M1UK differs from progenitor M1global genotype by 27 single-nucleotide polymorphisms and is characterized by increased speA superantigen expression in vitro.
Methods: An allele-specific real-time polymerase chain reaction assay was developed for the rapid detection of M1UK strains. The assay was used in combination with whole genome sequencing to determine emm (sub)type distribution for 51 invasive (n = 9) and noninvasive (n = 42) S pyogenes clinical isolates.
Results: Emm1 was the most prevalent S pyogenes emm serotype (n = 11) in this set of clinical isolates, with M1UK being the dominant emm1 genotype (4/5 invasive, 3/6 noninvasive isolates). The assay accurately detected M1UK strains. Whole genome sequencing revealed continued presence of Australian M1UK sublineages associated with epidemic scarlet fever-causing S pyogenes in Asia.
Conclusions: Our study establishes a suitable target for detection of the toxigenic M1UK and confirms the maintenance of M1UK strains in Queensland, Australia. This assay can be deployed in laboratories and provides a valuable, cost-effective tool to enhance surveillance of the expanding M1UK clone.
Keywords: Streptococcus pyogenes; ssrA SNP; M1UK; real-time PCR; scarlet fever.
© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. The authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Figures
References
-
- Brueggemann AB, Jansen van Rensburg MJ, Shaw D, et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. Lancet Digit Health 2021; 3:e360–70. - PMC - PubMed
-
- Amarsy R, Fournier S, Trystram D, et al. Decrease of hospital- and community-acquired bloodstream infections due to Streptococcus pneumoniae and Streptococcus pyogenes during the first year of the COVID-19 pandemic: a time-series analysis in Paris region. Am J Infect Control 2023; 51:475–7. - PMC - PubMed
-
- World Health Organization . Increased incidence of scarlet fever and invasive group A Streptococcus infection—multi-country. 2022. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON429. Accessed 7 February 2024.
-
- Centers for Disease Control and Prevention . Increase in pediatric invasive group A streptococcal infections. 2022. https://emergency.cdc.gov/han/2022/han00484.asp. Accessed 7 February 2024.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
